FindTrial
Sign In

Research on microRNA 21 levels in blood cancer

A study on expression of microRNA 21 in chronic lympho-proliferative disorders - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075106
Enrollment
15
Registered
2024-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age 12 year who are newly diagnosed cases of chronic lympho-proliferative disorders. 2.Patients willing to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with acute leukemia. 2.Patients with chronic myeloproliferative neoplasm.

Design outcomes

Primary

MeasureTime frame
expression of microRNA 21 in chronic lympho-proliferative disorders.Timepoint: At baseline—

Secondary

MeasureTime frame
correlation of microRNA 21 with clinical staging of lympho-proliferative disorders.Timepoint: At baseline—

Countries

India

Contacts

Public ContactDr Rahul Yadav

Maulana Azad Medical college

drsunita.mamc@gmail.com9968281414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026